Delva Shamley
Overview
Explore the profile of Delva Shamley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kruger B, Shamley D, Soko N, Dandara C
Clin Transl Sci
. 2024 Mar;
17(3):e13761.
PMID: 38476074
Tamoxifen, a selective estrogen receptor modulator, is used to treat hormone receptor-positive breast cancer. Tamoxifen acts as a prodrug, with its primary therapeutic effect mediated by its principal metabolite, endoxifen....
2.
Soko N, Muyambo S, Dandara M, Kampira E, Blom D, Jones E, et al.
J Pers Med
. 2023 Aug;
13(8).
PMID: 37623436
Pharmacogenomics may improve patient care by guiding drug selection and dosing; however, this requires prior knowledge of the pharmacogenomics of drugs commonly used in a specific setting. The aim of...
3.
Firfirey F, Shamley D, September A
Genes (Basel)
. 2023 Jan;
14(1).
PMID: 36672750
Chronic shoulder pain and disability is a common adverse effect experienced by >40% of breast cancer survivors (BCS). Pain management protocols for acute and chronic pain include the use of...
4.
Firfirey F, September A, Shamley D
Pharmacogenomics
. 2022 Jun;
23(9):513-530.
PMID: 35727214
Chronic shoulder pain/disability is a well-recognized side effect of treatment for breast cancer, with ∼40% of patients experiencing this, despite receiving pain management. To manage acute and chronic pain, several...
5.
Loehrer P, Carpten J, Gopal S, Shamley D
Am Soc Clin Oncol Educ Book
. 2022 May;
42:1-6.
PMID: 35522911
Conducting clinical research in low- and middle-income countries is essential to address the global impact of cancer. In 2017, ASCO convened an Academic Global Oncology Task Force that recommended an...
6.
Ezenwankwo E, Nnate D, Usoro G, Onyeso C, Anieto I, Ibeneme S, et al.
BMC Health Serv Res
. 2022 Feb;
22(1):236.
PMID: 35189864
Background: Addressing questions surrounding the feasibility of embedding exercise service units in clinical oncology settings is imperative for developing a sustainable exercise-oncology clinical pathway. We examined available literature and offered...
7.
Ezenwankwo E, Motsoeneng P, Atterbury E, Albertus Y, Lambert E, Shamley D
Support Care Cancer
. 2022 Jan;
30(6):4617-4633.
PMID: 35064329
Purpose: This mixed studies synthesis sought to evaluate structured patient education interventions (PEIs) to elucidate relevant conditions and mechanisms for increasing physical activity behavior in men with prostate cancer (PCa)....
8.
Mafu T, September A, Shamley D
Hum Genomics
. 2021 Jun;
15(1):36.
PMID: 34162438
Background And Purpose: Shoulder morbidity following breast cancer treatment is multifactorial. Despite several treatment- and patient-related factors being implicated, unexplained inter-individual variability exists in the development of such morbidity. Given...
9.
Shamley D, Ezeani A, Okoye I
JCO Glob Oncol
. 2021 Apr;
7:572-576.
PMID: 33886365
Oncology clinical trials are requisite for testing the safety and effectiveness of promising treatments and deciphering new knowledge into concrete benefits for patients. They present opportunities to innovate promising, novel...
10.
Odedina F, Shamley D, Okoye I, Ezeani A, Ndlovu N, Dei-Adomakoh Y, et al.
JCO Glob Oncol
. 2020 Jul;
6:932-941.
PMID: 32614728
Purpose: The burden of cancer in Africa is of significant concern for several reasons, including that incidence of cancer in Africa continues to rise while Africa is also dealing with...